SCHEMBL20565375

SCHEMBL20565375

COCCOCOc1ccc(C23CC4CC(CC(C4)C2)C3)cc1-c1ccc2cc(C(=O)OC)ccc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 4/20 0.48
RARA P10276 4/20 0.47
HIF1A Q16665 5/20 0.47
EPAS1 Q99814 2/20 0.47
MDH1 P40925 1/20 0.47
MDH2 P40926 1/20 0.47
EP300 Q09472 1/20 0.47
RARG P13631 8/20 0.46
RARB P10826 2/20 0.46
MEN1 O00255 1/20 0.45
NR1I2 O75469 1/20 0.45
LMNA P02545 1/20 0.45
PGR P06401 1/20 0.45
HSPD1 P10809 1/20 0.45
GOT1 P17174 1/20 0.45
GLRA1 P23415 1/20 0.45
BLM P54132 1/20 0.45
HSPE1 P61604 1/20 0.45
KMT2A Q03164 1/20 0.45
TDP1 Q9NUW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25230655 0.86 IKBKB (0.61) IKBKBRARAHIF1AEPAS1MDH1
SCHEMBL30428692 0.86 IKBKB (0.61) IKBKBRARAHIF1AEPAS1MDH1
SCHEMBL20565088 0.82 IKBKB (0.47) IKBKBRARAHIF1AEPAS1MDH1
SCHEMBL7927677 0.80 IKBKB (0.53) IKBKBRARAHIF1AEPAS1MDH1
SCHEMBL19639432 0.80 RARA (0.67) IKBKBRARAHIF1AEPAS1MDH1
SCHEMBL8766811 0.78 RARB (0.57) IKBKBRARAHIF1AEPAS1MDH1
SCHEMBL3315794 0.78 RARB (0.56) RARAHIF1AEPAS1MDH1MDH2
SCHEMBL27979397 0.76 RARB (0.55) RARARARGRARBMEN1NR1I2
SCHEMBL7932786 0.76 IKBKB (0.55) IKBKBRARAHIF1ARARGRARB
SCHEMBL9300824 0.76 RARB (0.71) IKBKBRARAHIF1AEPAS1RARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12195424-B2 Antibiotic compounds THE GENERAL HOSPITAL CORPORATION (US) 2025-01-14 US disclosed
US-20220095614-A1 Antibiotic Compounds THE GENERAL HOSPITAL CORPORATION 2022-03-31 US disclosed
US-11278025-B2 Antibiotic compounds THE GENERAL HOSPITAL CORPORATION (US) 2022-03-22 US disclosed
US-20200190009-A1 Antibiotic Compounds TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2020-06-18 US disclosed
WO-2018213609-A1 ANTIBIOTIC COMPOUNDS AUSUBEL FREDERICK M (US) 2018-11-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190009-A1 Antibiotic Compounds CUTA, NRDC, CLPP IKBKB 2203/4885RARA 30/4885HIF1A 2511/4885
US-20220095614-A1 Antibiotic Compounds CUTA, NRDC, CLPP IKBKB 2203/4885RARA 30/4885HIF1A 2511/4885
US-12195424-B2 Antibiotic compounds CUTA, NRDC, CLPP IKBKB 2203/4885RARA 30/4885HIF1A 2511/4885
US-11278025-B2 Antibiotic compounds CUTA, NRDC, CLPP IKBKB 2203/4885RARA 30/4885HIF1A 2511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.